Anne Uyei

Atezolizumab, vemurafenib, and cobimetinib as first-line treatment for unresectable advanced BRAFV600 mutation-positive melanoma (IMspire150): primary analysis of the randomised, double-blind, placebo-controlled, phase 3 trial

Ralf Gutzmer, Daniil Stroyakovskiy, Helen Gogas et al. · The Lancet · 2020 · 631 citations

Medicine, Melanoma, Immunology +9

Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial

Cathy Eng, Tae Won Kim, Johanna C. Bendell et al. · The Lancet Oncology · 2019 · 543 citations · Full text

Cobimetinib Versus Regorafenib, Oncology, Medicine +10

Treatment of Metastatic Breast Cancer with Trastuzumab and Vinorelbine During Pregnancy

Michelle A. Fanale, Anne Uyei, Richard L. Theriault et al. · Clinical Breast Cancer · 2005 · 95 citations

Metastatic Breast Cancer, Breast Oncology, Medicine +5

Association between clinical characteristics and risk‐reduction interventions in women who underwent <i>BRCA1</i> and <i>BRCA2</i> testing

Anne Uyei, Susan K. Peterson, Julie Erlichman et al. · Cancer · 2006 · 72 citations

Prophylactic Bilateral Salpingo-Oophorectomy Compared With Surveillance in Women With BRCA Mutations

Kathleen M. Schmeler, Charlotte C. Sun, Diane C. Bodurka et al. · Obstetrics and Gynecology · 2006 · 61 citations